We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GWW:NYSEW.W. Grainger, Inc. Analysis

Data as of 2026-03-10 - not real-time

$1,115.28

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

The stock is trading just above a key support zone identified by recent price action. A 20‑day moving average sits above the 50‑day average, signaling a bullish bias despite a modest pullback. The MACD histogram remains in negative territory, indicating short‑term momentum weakness. Volume has been trending lower, which may limit upside momentum in the near term. Recent earnings showed a slight miss on GAAP EPS versus consensus, though revenue grew in line with expectations. The company delivered solid top‑line growth of roughly mid‑single digits year‑over‑year. Valuation metrics suggest the market price is substantially above intrinsic estimates, pointing to an overvalued condition. The price‑to‑earnings multiple exceeds the industry average, reinforcing the premium valuation. Nonetheless, the dividend yield, while modest, is backed by a low payout ratio and robust cash generation. Overall, the technical picture is mixed, with bullish trend cues offset by weakening momentum and elevated valuation.
The balance sheet shows ample cash relative to debt and a strong return on equity, supporting dividend sustainability. Exposure is concentrated in North America with ancillary operations in Japan and the United Kingdom, giving the business moderate geographic diversification. Sector dynamics are relatively stable, and regulatory headwinds are limited, resulting in low to medium risk across those dimensions. Given the combination of solid fundamentals and a premium price, a cautious stance is warranted. We therefore recommend holding in the short‑ to medium‑term while monitoring valuation and momentum, with a longer‑term view that could become more favorable if the price gap narrows.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near support
  • decreasing volume
  • negative MACD histogram

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • steady revenue growth
  • strong cash flow and dividend coverage
  • overvalued price but solid fundamentals

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • high ROE and recurring revenue base
  • sustainable dividend
  • potential valuation compression

Key Metrics & Analysis

Financial Health

Revenue Growth4.50%
Profit Margin9.51%
P/E Ratio31.5
ROE46.10%
ROA19.03%
Debt/Equity69.11
P/B Ratio14.2
Op. Cash Flow$2.0B
Free Cash Flow$1.1B
Industry P/E29.5

Technical Analysis

TrendBullish
RSI47.8
Support$1,083.33
Resistance$1,218.63
MA 20$1,139.32
MA 50$1,093.14
MA 200$1,023.27
MACDBearish
VolumeDecreasing
Fear & Greed Index75.89

Valuation

Fair Value$337.63
Target Price$1,143.88
Upside/Downside2.56%
GradeOvervalued
TypeGrowth
Dividend Yield0.81%

Risk Assessment

Beta0.68
Volatility33.61%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.